HAWK RESOURCES LIMITED. — Capital/Financing Update 2018

Dec 26, 2018

ASX ANNOUNCEMENT 24 December 2018

Cancellation and Lapse of Options

Following is an Appendix 3B in relation to the cancellation and lapse of the following employee & consultant incentive options:-

• 500,000 options exercisable at $2.50, expiring on 30/11/2021

• 500,000 options exercisable at $3.00, expiring on 30/11/2021

• 500,000 options exercisable at $3.50, expiring on 30/11/2021 & vesting on 1/11/2019

• 500,000 options exercisable at $4.00, expiring on 30/11/2021 & vesting on 1/11/2020

• 25,000 options exercisable at $2.50, expiring on 02/11/2021

• 25,000 options exercisable at $3.00, expiring on 02/11/2021

• 25,000 options exercisable at $3.50, expiring on 02/11/2021 & vesting on 16/10/2019

• 25,000 options exercisable at $4.00, expiring on 02/11/2021 & vesting on 16/10/2020

• 50,000 options exercisable at $3.50, expiring on 15/11/2021 & vesting on 01/09/2019

• 50,000 options exercisable at $4.00, expiring on 15/11/2021 & vesting on 01/09/2020

A change of Director Interest notice for Mr Bruno Hegner is also following due to the cancellation of options held by Mr Hegner, included above.

Brett Tucker Company Secretary

ALDERAN RESOURCES LIMITED

Ground Floor, 16 Ord Street, West Perth, 6005, WA

www.alderanresources.com.au

For further information:

e: info@alderanresources.com.au p: +61 8 9482 0560

ABN: 55 165 079 201

Please direct enquiries to:

Christopher Wanless

Chief Executive Officer

info@alderanresources.com.au

Stay Connected

Interested investors and shareholders are encouraged to subscribe to the Company’s social media channels using the links below:

==> picture [91 x 34] intentionally omitted <==

==> picture [103 x 33] intentionally omitted <==

1

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Alderan Resources Limited

ABN

55 165 079 201

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of +securities issued or to be issued 2 Number of[+] securities issued or to be issued (if known) or maximum number which may be issued

3 Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

• See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

Appendix 3B New issue announcement

4 Do the+securities rank equally in all respects from the+issue date with an existing+class of quoted+securities? If the additional+securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) 6a Is the entity an+eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the+securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security holder resolution under rule 7.1A was passed 6c Number of+securities issued without security holder approval under rule 7.1 6d Number of+securities issued with security holder approval under rule 7.1A
	Yes
	21 November 2018
	Nil
	Nil

• See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

Appendix 3B New issue announcement

6e Number of[+] securities issued Nil with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of[+] securities issued Nil under an exception in rule 7.2 6g If[+] securities issued under rule N/A 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. 6h If[+] securities were issued under N/A rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining See annexure issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. Number +Class 8 Number and +class of all 129,608,908 Fully Paid Ordinary Shares +securities quoted on ASX ( including the +securities in - 44,346,524 shares subject to section 2 if applicable) ASX escrow to 09/06/19

• See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

Appendix 3B New issue announcement

9 Number and +class of all +securities not quoted on ASX (_including_the +securities in section 2 if applicable)	Number	+Class
	755,000 2,300,000 1,570,000 1,570,000 1,570,000 1,777,454 2,300,000 2,300,000 45,000 75,000 75,000 75,000 200,000 200,000 200,000 200,000 75,000	Unlisted options, exercisable at $0.20, expiring 22/02/2021 Unlisted options, exercisable at $0.30, expiring 22/02/2021 Unlisted options, exercisable at $0.40, expiring 22/02/2021 Unlisted options, exercisable at $0.60, expiring 22/02/2021, vesting on 22/02/2019 Unlisted options, exercisable at $0.80, expiring 22/02/2021, vesting on 22/02/2019 Unlisted options, exercisable at $0.20 expiring 22/02/2020 Unlisted options, exercisable at $0.30 expiring 31/05/2020, Unlisted options, exercisable at $0.40 expiring 31/05/2020 Unlisted options exercisable at $0.30, expiring on 27/06/2021 Unlisted options exercisable at $0.40, expiring on 27/06/2021 Unlisted options exercisable at $0.60, expiring on 27/06/2021 Unlisted options exercisable at $0.80, expiring on 27/06/2021 Unlisted options exercisable at $0.60, expiring on 22/02/2021, vesting on 04/09/18 Unlisted options exercisable at $0.80, expiring on 22/02/2021 Unlisted options exercisable at $1.00, expiring on 22/02/2021 Unlisted options exercisable at $1.20, expiring on 22/02/2021 Unlisted options exercisable at $2.50,expiringon 15/11/2021

• See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Appendix 3B New issue announcement

10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)	75,000 25,000 25,000 166,666 233,3334 116,666 233,334 116,666 233,334 116,666 233,334 600,000	Unlisted options exercisable at $3.00, expiring on 15/11/2021 Unlisted options exercisable at $3.50, expiring on 15/11/2021, vesting on 1/9/2019 Unlisted options exercisable at $4.00, expiring on 15/11/2021, vesting on 1/9/2020 Unlisted options exercisable at $1.00 each, expiring 12/06/2022, vesting on 12/06/2019 Unlisted options exercisable at $1.00 each, expiring 12/06/2022, vesting on 12/06/2020 Unlisted options exercisable at $1.50 each, expiring 12/06/2022, vesting on 12/06/2019 Unlisted options exercisable at $1.50 each, expiring 12/06/2022, vesting on 12/06/2020 Unlisted options exercisable at $2.00 each, expiring 12/06/2022, vesting on 12/06/2019 Unlisted options exercisable at $2.00 each, expiring 12/06/2022, vesting on 12/06/2020 Unlisted options exercisable at $2.50 each, expiring 12/06/2022, vesting on 12/06/2019 Unlisted options exercisable at $2.50 each, expiring 12/06/2022, vesting on 12/06/2020 Performance rights
	N/A

Part 2 - Pro rata issue - NOT APPLICABLE, DELETED

• See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

Appendix 3B New issue announcement

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

• 34 Type of[+] securities ( tick one )

• (a) +Securities described in Part 1

• (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

38 Number of[+] securities for which +quotation is sought 39 +Class of +securities for which quotation is sought

• See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Appendix 3B New issue announcement

40 Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state:

• the date from which they do

• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

41 Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another[+] security, clearly identify that other[+] security)

42

Number and +class of all +securities quoted on ASX ( including the[+] securities in clause 38)

Number +Class

Quotation agreement

• 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

• 2 We warrant the following to ASX.

• The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

• There is no reason why those[+] securities should not be granted +quotation.

• See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

Appendix 3B New issue announcement

• An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

  • Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

• If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

• 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

• 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: Date: 24 December 2018 Company secretary

Print name: Brett Tucker

== == == == ==

• See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Appendix 3B New issue announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

• Insert number of fully paid[+] ordinary 107,963,908 securities on issue 12 months before the + issue date or date of agreement to issue Add the following: 30,000 – 9 August 2018

• • Number of fully paid[+] ordinary securities issued in that 12 month period under an 1,615,000 – 11 September 2018 exception in rule 7.2 5,000,000 – 24 August 2018 15,000,000 – approved by shareholders on

• • Number of fully paid[+] ordinary securities 21 November 2018

• issued in that 12 month period with shareholder approval

• • Number of partly paid[+] ordinary securities that became fully paid in that 12 month period

• Note: • Include only ordinary securities here – other classes of equity securities cannot be added

• • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• • It may be useful to set out issues of securities on different dates as separate line items

• Subtract the number of fully paid[+] ordinary Nil securities cancelled during that 12 month period “A” 129,608,908

• See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Appendix 3B New issue announcement

Step 2: Calculate 15% of “A”

“B” 0.15 [Note: this value cannot be changed] Multiply “A” by 0.15 19,441,336

Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used

Insert number of[+] equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded – not just ordinary securities

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

“C”

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1

“A” x 0.15 19,441,336 Note: number must be same as shown in Step 2 Subtract “C” Note: number must be same as shown in Step 3 Total [“A” x 0.15] – “C” 19,441,336 [Note: this is the remaining placement capacity under rule 7.1]

• See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Appendix 3B New issue announcement

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 129,608,908 Note: number must be same as shown in Step 1 of Part 1

Step 2: Calculate 10% of “A”

“D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 12,960,891

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of[+] equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities – not just ordinary securities

• Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• • It may be useful to set out issues of securities on different dates as separate line items

• “E”

• See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A	Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A
“A” x 0.10 Note: number must be same as shown in Step 2	12,960,891
Subtract“E” Note: number must be same as shown in Step 3
Total[“A” x 0.10] – “E”	12,960,891 Note: this is the remaining placement capacity under rule 7.1A

• See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of entity Alderan Resources Limited ACN 165 079 201

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr Frank D Hegner
Date of last notice	19 September 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	24 December 2018
No. of securities held prior to change	- 500,000 Unlisted options exercisable at $2.50, expiring on 30/11/2021 - 500,000 Unlisted options exercisable at $3.00, expiring on 30/11/2021 - 500,000 Unlisted options exercisable at $3.50, expiring on 30/11/2021, vesting on 1/11/2019 - 500,000 Unlisted options exercisable at $4.00, expiring on 30/11/2021, vesting on 1/11/2020 - 600,000 Performance rights on the terms and conditions detailed in the Notice of Meeting dated 26 July 2018
Class	Unlisted options

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number acquired	Nil
Number disposed	- 500,000 Unlisted options exercisable at $2.50, expiring on 30/11/2021 - 500,000 Unlisted options exercisable at $3.00, expiring on 30/11/2021 - 500,000 Unlisted options exercisable at $3.50, expiring on 30/11/2021, vesting on 1/11/2019 - 500,000 Unlisted options exercisable at $4.00, expiring on 30/11/2021, vesting on 1/11/2020
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil
No. of securities held after change	600,000 Performance rights on the terms and conditions detailed in the Notice of Meeting dated 26 July 2018
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation inbuy-back	Cancellation of options

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
**Date of change **
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to whichtheinteresthas changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 – +Closed period

Part 3 – +Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002